Literature DB >> 16969740

Postresuscitative intensive care: neuroprotective strategies after cardiac arrest.

Wendy L Wright1, Romergryko G Geocadin.   

Abstract

Cardiac arrest is a common disease in the United States, and many patients will die as a result of the neurological damage suffered during the anoxic period, or will live in a neurologically debilitated state. When cardiopulmonary-cerebral resuscitation results in the return of spontaneous circulation, intensive care is required to optimize neurological recovery. Such "brain-oriented" therapies include routine care, such as positioning and maintenance of volume status; optimization of cerebral perfusion, with the use of vasopressors if needed; management of increased intracranial pressure with agents such as hypertonic saline; assuring adequate oxygenation and avoiding hypercapnia; aggressive fever control; intensive glucose control, with the use of an insulin drip if needed; and management of seizures if they occur. To date, no neuroprotectant medications have been shown to improve neurological outcome. Induced moderate therapeutic hypothermia is utilized as a neuroprotective maneuver. Future treatment options and advanced monitoring techniques are also discussed. Further study to optimize neuroprotective strategies when treating patients who survive cardiac arrest is needed.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16969740     DOI: 10.1055/s-2006-948320

Source DB:  PubMed          Journal:  Semin Neurol        ISSN: 0271-8235            Impact factor:   3.420


  8 in total

1.  A national analysis of the relationship between hospital factors and post-cardiac arrest mortality.

Authors:  Brendan G Carr; Munish Goyal; Roger A Band; David F Gaieski; Benjamin S Abella; Raina M Merchant; Charles C Branas; Lance B Becker; Robert W Neumar
Journal:  Intensive Care Med       Date:  2008-10-21       Impact factor: 17.440

2.  Successful cardiopulmonary resuscitation following cardiac arrest in a hypoglycemic cat.

Authors:  Fergal M McDermott; Kerrie A Lewis
Journal:  Can Vet J       Date:  2020-02       Impact factor: 1.008

3.  The probability of seizures during EEG monitoring in critically ill adults.

Authors:  M Brandon Westover; Mouhsin M Shafi; Matt T Bianchi; Lidia M V R Moura; Deirdre O'Rourke; Eric S Rosenthal; Catherine J Chu; Samantha Donovan; Daniel B Hoch; Ronan D Kilbride; Andrew J Cole; Sydney S Cash
Journal:  Clin Neurophysiol       Date:  2014-07-11       Impact factor: 3.708

Review 4.  Management of brain injury after resuscitation from cardiac arrest.

Authors:  Romergryko G Geocadin; Matthew A Koenig; Xiaofeng Jia; Robert D Stevens; Mary Ann Peberdy
Journal:  Neurol Clin       Date:  2008-05       Impact factor: 3.806

5.  Activation of Neuropeptide Y2 Receptor Can Inhibit Global Cerebral Ischemia-Induced Brain Injury.

Authors:  Reggie Hui-Chao Lee; Celeste Yin-Chieh Wu; Cristiane T Citadin; Alexandre Couto E Silva; Harlee E Possoit; Garrett A Clemons; Christina H Acosta; Victoria A de la Llama; Jake T Neumann; Hung Wen Lin
Journal:  Neuromolecular Med       Date:  2021-05-21       Impact factor: 4.103

6.  Use of the trendelenburg position in the porcine model improves carotid flow during cardiopulmonary resuscitation.

Authors:  Filiberto Zadini; Edward Newton; Amin A Abdi; Jay Lenker; Giorgio Zadini; Sean O Henderson
Journal:  West J Emerg Med       Date:  2008-11

Review 7.  Improving neurological outcome after cardiac arrest: Therapeutic hypothermia the best treatment.

Authors:  Suchitra Malhotra; Satyavir S Dhama; Mohinder Kumar; Gaurav Jain
Journal:  Anesth Essays Res       Date:  2013 Jan-Apr

8.  Renal Insufficiency and Early Bystander CPR Predict In-Hospital Outcomes in Cardiac Arrest Patients Undergoing Mild Therapeutic Hypothermia and Cardiac Catheterization: Return of Spontaneous Circulation, Cooling, and Catheterization Registry (ROSCCC Registry).

Authors:  Anjala Chelvanathan; David Allen; Hilary Bews; John Ducas; Kunal Minhas; Minh Vo; Malek Kass; Amir Ravandi; James W Tam; Davinder S Jassal; Farrukh Hussain
Journal:  Cardiol Res Pract       Date:  2016-01-18       Impact factor: 1.866

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.